271 related articles for article (PubMed ID: 8096132)
1. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
3. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
[TBL] [Abstract][Full Text] [Related]
4. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
[TBL] [Abstract][Full Text] [Related]
5. Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460).
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(4):703-6. PubMed ID: 2861823
[TBL] [Abstract][Full Text] [Related]
6. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
7. Antisecretory effects of two new histamine H2-receptor antagonists.
Bickel M; Herling AW; Rising TJ; Wirth K
Arzneimittelforschung; 1986 Sep; 36(9):1358-63. PubMed ID: 2878669
[TBL] [Abstract][Full Text] [Related]
8. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
[TBL] [Abstract][Full Text] [Related]
9. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
Katz LB; Tobia AJ; Shriver DA
J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
[TBL] [Abstract][Full Text] [Related]
10. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
11. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
14. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
15. Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism.
Ichikawa T; Ishihara K; Saigenji K; Hotta K
Br J Pharmacol; 1997 Nov; 122(6):1230-6. PubMed ID: 9401791
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
17. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
Lin TM; Evans DC; Warrick MW; Pioch RP
J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
[TBL] [Abstract][Full Text] [Related]
18. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.
Takagi T; Takeda M; Maeno H
Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219
[TBL] [Abstract][Full Text] [Related]
19. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]